Citius Oncology (NASDAQ:CTOR) reported quarterly earnings results on February 13, 2026 that fell short of analyst expectations.
The Healthcare company reported earnings per share of $-0.06, missing the consensus estimate of $-0.04 by $0.02 per share. Revenue came in at $3.9M, missing the estimate of $4.4M.
Citius Oncology's stock moved following the earnings release. The stock currently trades at $1.22 with a market capitalization of $96.0M.